申请人:[en]SCHRÖDINGER, INC.
公开号:WO2024107393A1
公开(公告)日:2024-05-23
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases such as cancer.